Rhodacyanine derivative selectively targets cancer cells and overcomes tamoxifen resistance.

PLoS One · 2012 · PMC3338522 · PMID 22563386

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

not significantly significantno p-value reported

Tukey's post-hoc test revealed that 4 hour YM-1 followed by 4-OHT was significantly different from the 4-OHT 48 hours treatment (p<0.05), whereas both the 48 hour 10 μM YM-1 and the 4 hour 10 μM YM-1 followed by 95% EtOH treatments were not significantly significant from the 4-OHT 48 hour treatment ( Figure 4F ).

also in 164 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.